DYN
NASDAQ HealthcareDyne Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $18.06 |
|---|---|
| Volume | 2,436,528 |
| Market Cap | 2.98B |
| Beta | 1.400 |
| RSI (14-Day) | 63.2 |
| 200-Day MA | $15.27 |
| 50-Day MA | $17.13 |
| 52-Week High | $25.00 |
| 52-Week Low | $6.36 |
| Forward P/E | -5.92 |
| Price / Book | 3.06 |
🎯 Investment Strategy Scores
How DYN scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
16/100
High dividend yield + low volatility
🚀 Moon Shot
47/100
High growth potential (high beta + oversold)
🔪 Falling Knife
11/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
90/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
49/100
Large-cap, institutional-quality stocks
Find DYN in your text
Paste any text on the homepage — the tool will extract DYN and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.